| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.77B | +4.5% |
| Gross Profit | $333.6M | -2.6% |
| R&D Expense | $69.6M | +19.7% |
| SG&A Expense | $274.9M | +8.9% |
| Operating Income | -$21.5M | -13.0% |
| Pre-tax Income | -$20.2M | -28.7% |
| Income Tax | $2.5M | +131.6% |
| Net Income | -$22.7M | -6.8% |
| EPS (Basic) | -$0.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.2M | +9.4% |
| Accounts Receivable | $108.8M | +24.1% |
| Current Assets | $304.9M | +13.8% |
| Total Assets | $442.5M | +13.2% |
| Current Liabilities | $199.7M | +7.5% |
| Total Liabilities | $199.7M | +7.5% |
| Stockholders' Equity | $242.8M | +18.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $118.6M | -38.1% |
| Capital Expenditures | $9.6M | +47.6% |
| Investing Cash Flow | -$23.5M | -20.6% |
| Financing Cash Flow | -$86.5M | +49.2% |
| Free Cash Flow | $109.0M | -41.1% |
| +0.0% |
| EPS (Diluted) | -$0.14 | +0.0% |